Signaling Pathways
Product Name | CAS No. | Specification | Application | Registration |
Atazanavir-D6 | 1092540-50-5 | 98+% | ||
Bexarotene-D4 | 2182068-00-2 | 98+% | ||
Cobimetinib (GDC-0973; XL518) | 934660-93-2 | 98+% | ||
(+)-PD 128907 Hydrochloride | 300576-59-4 | 99+% | ||
Sulopenem Etzadroxil | 1000296-70-7 | 98+% | ||
15(S)-Latanoprost | 145773-22-4 | 98+% | ||
Maxacalcitol (22-Oxacalcitriol) | 103909-75-7 | 99+% | ||
Vandetanib (ZD6474) | 443913-73-3 | 98+% | ||
N-Acetyl-β-Asp-Glu (β-NAAG) | 4910-46-7 | 98+% | ||
Luminol | 521-31-3 | 99+% | ||
Prucalopride Succinate | 179474-85-2 | 99+% | ||
Eletriptan Hydrobromide | 177834-92-3 | 99+% | ||
Oseltamivir Phosphate | 204255-11-8 | 98+% | ||
Doxylamine Succinate | 562-10-7 | 98+% | ||
Atorvastatin Calcium salt | 344423-98-9 | 98+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks